Article Text
Abstract
Objective To design software to assist health care providers with contraceptive counselling.
Methods The Model-View-Controller software architecture pattern was used. Decision logic was incorporated to automatically compute the safety category of each contraceptive option. Decisions are made according to the specific characteristics or known medical conditions of each potential contraception user. The software is an app designed for the iOS and Android platforms and is available in four languages. iContraception® facilitates presentation of visual data on medical eligibility criteria for contraceptive treatments.
Results The use of this software was evaluated by a sample of 54 health care providers. The general satisfaction with the use of the app was over 8 on a 0–10 visual analogue scale in 96.3% of cases.
Conclusions iContraception provides easy access to medical eligibility criteria of contraceptive options and may help with contraceptive counselling.
- counselling
- education and training
- family planning service provision
- reproductive health politics
- needs assessment
Statistics from Altmetric.com
- counselling
- education and training
- family planning service provision
- reproductive health politics
- needs assessment
Key messages
iContraception® is an app for smartphones or tablets that provides health care professionals with easy access to World Health Organization (WHO) eligibility criteria for contraceptive options.
This software includes automatic assignment of WHO category for any contraceptive option taking into account the patient's habits and medical conditions, thus helping the health provider select an appropriate contraceptive method.
Use of this software is intuitive and the interface design is highly appreciated by those who have tested the app.
Introduction
A wide range of effective contraceptive methods is available, with countless publications on their benefits, risks and limitations. This information is available for health care providers through institutions such as the World Health Organization (WHO), the UK Faculty of Sexual & Reproductive Healthcare (FSRH) and the USA Centers for Disease Control and Prevention (CDC). However, 50% of pregnancies in the USA remain unplanned1 and 22% of all pregnancies end in abortion.2 Excluding the fact that no method achieves 100% effectiveness even with perfect use, two main causes are behind this ‘contraceptive failure’: (1) the client does not seek the help of a health care provider and (2) the advice of the health care provider fails. One approach to address this issue would be to keep in direct contact with the client. In this way, for example, clear short messages via mobile phones have been demonstrated to be useful in countries in which health care providers are not easily accessed.3 Another possibility would be to improve medical advice to assist providers to develop their skills and knowledge. The aim of initiatives from the WHO,4 the FSRH5 and, more recently, the CDC is to bring contraceptive information closer to the health care provider.6 Following this concept and taking advantage of new technologies, we developed a software tool to assist health care providers in contraceptive counselling tasks.
Methods
Development phases
This app was developed following the Model-View-Controller software architecture pattern. The first step was the collection of information. The WHO Medical Eligibility Criteria for Contraceptive Use7 was the main source for the scientific basis of this app. Second, all tables with treatments, conditions and medical criteria were converted into an electronic database format (app ‘Model’). The next step was the development of an interface (app ‘View’) in which the user is able to input multiple patient conditions and visualise the results of the medical criteria computed. Subsequently, the decision logic, which computes the WHO safety and eligibility criteria of each contraceptive option for all selected medical conditions automatically (app ‘Controller’), was implemented. Finally, the app was tested and debugged with potential users.
Operation of the App
Once downloaded and installed on the smartphone or tablet from ‘Google Play’ or ‘app Store’ [Android and iOS (apple mobile operating system) platforms, respectively] its usage is intuitive and simple (Figure 1). In the first tab, the patient conditions (personal characteristics and known medical conditions) are selected as appropriate, and in the second tab the safety category of each treatment is displayed. The safety category is automatically computed each time a new condition is added, modified or deleted. In addition to the number code defined by WHO, a colour code has been assigned to each number (1: blue, 2: yellow, 3: orange; 4: red). For treatments in Category 2 and above, additional information is displayed on selection of the category, with evidence and clarifications.
Evaluation of use
To test the applicability and satisfaction with the use of the app, a survey was conducted among 54 health care providers (6 nurses, 10 primary care doctors and 38 gynaecologists) who were currently users of the app. The survey was designed by the authors and the app-quality service using a visual analogue scale (VAS), quantitatively scoring the following aspects of the app from 0 to 10:
usefulness in contraception assessment
user friendliness
scientific quality
first-time user experience
performance
intuitive design
general satisfaction.
In addition, other qualitative points were assessed: positive and negative aspects to be highlighted, suggestions for improvement and promotion of app use.
Results
Data related to the use of the app are shown in Table 1. The mean scores for the usefulness and scientific quality of the app were 8.83 and 8.89, respectively. In the interview, all app-related parameters were over 8.8 in a 0–10 VAS (Table 1). Moreover, 53 users stated that they would recommend the app to other health care providers. Finally, 25 users answered the questions related to positive and negative characteristics of the app. The most common positive comment was the friendliness of use (n=22/25). Only one negative comment was recorded, relating to the lack of updates of the data contained in the app.
Discussion
The influence of contraceptive advice in user selection of birth control treatment and its correct usage is important.8 Furthermore, the possibilities offered by new technologies to directly or indirectly help users through health care providers6 are promising.
iContraception© helps the provider and client to decide on the choice of method by considering the available evidence, and enhancing provider knowledge achieves better contraceptive selection. Its free availability to any health care provider, anywhere in the world, provides an unquestionable advantage. It does not substitute, but rather adds to other initiatives seeking to bring authoritative information to health care providers.4–7 ,9 Its novelty is to automatically integrate the medical conditions, habits and personal characteristics of patients, with the contraceptive treatments and their medical eligibility criteria. There is no need to search through all the documentation, thereby dramatically diminishing human errors and saving time. The speed of response and the graphical display encourages providers to use it.
Obviously, the app does not directly determine how the method is prescribed by the health care providers or used by the users, but it certainly helps in treatment choice, it safely detects the absence of contraindications, it may help to improve adherence and it provides good advice. All these aspects are factors that help to improve the quality of contraceptive advice.
iContraception is now available in four languages (English, French, Portuguese and Spanish), and it can be easily updated. Finally, and importantly, it can be downloaded free of charge from two platforms:
▸ Google play: https://play.google.com/store/apps/details?id=com.itiox.icontraception and
▸iTunes: https://itunes.apple.com/es/app/icontraception/id668520861?mt=8.
Acknowledgments
This app was created in collaboration between the authors, who were responsible for the scientific content, and ITIOX Tecnológica S.L. (Seville, Spain; http://www.itiox.com), who developed the app itself.
Footnotes
Funding The app has been developed with the support of the Andalusian Health Service in order to be offered free of cost to health care professionals. The app does not allow advertisements by any registered pharmaceutical product.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
Linked Articles
- Highlights from this issue